Paradigm Medical Names Charles Pritchard as Vice President of Sales and Marketing

SALT LAKE CITY, UT--(Marketwire - May 12, 2010) -

Highlighted Links

Paradigm Medical Industries

Paradigm Medical Industries, Inc. (PINKSHEETS: PDMI) announced today that Charles S. Pritchard has rejoined the Company as its Vice President of Sales and Marketing. Mr. Pritchard is a well known and respected sales manager in the ophthalmic community. He previously served as the National Sales Manager at Paradigm and, more recently, as National Sales Manager at Stereo Optics. Mr. Pritchard began work at Paradigm on May 11, 2010.

"I am extremely pleased to be able to lure Charles Pritchard back to our organization. He has exceptional marketing, sales and management skills. He will be an integral part of Paradigm's current and future growth plans," said Stephen Davis, Paradigm's President and Chief Executive Officer. Mr. Davis added, "Charles will report directly to me and will begin immediately to assist in the Company's efforts in selecting and supporting the independent domestic sales representatives. He will also be directly involved in Paradigm's international sales efforts."

About Paradigm Medical Industries, Inc.

Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes ophthalmic diagnostic instruments and related products for early detection of glaucoma and other eye disorders. The Company's primary objective is to capture a niche market within the glaucoma and ultrasound microscopy fields. The Company markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States and internationally.

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.